Cointime reports: Innovative drug stocks in China rose against the broader market trend, with Jinling Pharmaceutical hitting its second consecutive limit-up session. Haichuang Pharmaceutical gained more than 10%, while Lamei Pharmaceutical, Asymchem, Jenkem Technology and Guilin Sanjin each advanced more than 5%.
Chinese Innovative Drug Stocks Buck Market Trend; Jinling Pharmaceutical Up Two Straight Sessions
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
6m ago
S&P 500 Falls 2.0% to 7,498.13
6m ago
Nasdaq falls 3.3% as AI stocks sell off on Democratic midterm sweep
7m ago
US memory chip stocks extend selloff; SanDisk plunges over 17%
36m ago
Nvidia Falls 5.6%, Hitting Intraday Low Since April
43m ago
SanDisk, Western Digital, Seagate all fall over 11%; AMD drops 11%
44m ago
Tesla and SpaceX Shares Both Tumble on November 5